Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide tablets), as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus. Rybelsus®, the brand name for oral semaglutide in the US, is the first approved glucagon-like…

The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – has seen a surge in growth across domestic and international pharma companies, as well as a sizable rise in overall attendees. As reported earlier this year in the provisional findings of the CPhI…

GABA Therapeutics, a biotech company focused on the treatment of mood disorders, and ATAI Life Sciences, a global biotech company builder working on paradigm shifting interventions for unmet needs in the mental health space, announced a partnership to develop a novel compound that promises efficacy across a spectrum of mood…

Anixa Biosciences, Inc., a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that Potomac Urology Center, PC ("PUC") has joined its Cchek™ early cancer detection study.  PUC will provide patient samples for Anixa's ongoing prostate cancer study, including support of clinical validation of Anixa's…

Eisai Co., Ltd. has announced that Eisai's subsidiary Eisai Pharmaceuticals India Pvt. Ltd. and Mylan N. V. subsidiary Mylan India have entered into a license agreement to promote and distribute the second brand TECERIS for the anticancer agent eribulin mesylate (eribulin) in India. Under this agreement, eribulin will be supplied…

Eisai Co., Ltd. and Meiji Seika Pharma Co., Ltd. has announced the manufacturing and marketing approval in Japan for the indication of improvement of wearing-off phenomenon in patients with Parkinson's disease under treatment with a drug containing levodopa for Equfina TABLETS (safinamide mesilate, "safinamide"), which was developed for use in…

Saniona , a clinical stage biotech company focused on eating disorders and CNS, today announced that adolescent as well as adult patients with Prader-Willi syndrome (PWS) are expected to receive significant benefit on body weight, body mass index (BMI) and hyperphagia from once-daily oral Tesomet treatment. This conclusion is supported…

Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, announced today its Australian subsidiary has been awarded a $1.37 M AUD grant from the FightMND (Fight Motor Neuron Disease) foundation of Australia. The grant will substantially fund a clinical trial to assess the efficacy and safety of Clene's novel nanocatalyst, CNM-Au8, to…

Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together with Oracle cloud-based technologies into a single data management and…

LIPAC Oncology LLC and Huons Co., Ltd today announced that they have entered into an exclusive licensing agreement to develop, manufacture and commercialize TSD-001 for all indications in Korea. Huons is making an upfront payment and future milestone payments to LIPAC based on specific development, regulatory and commercial milestones. Huons…

loader